NPI 1801859178: Open Payments
NPI 1801859178. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$126 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $215 · 2025 $126
Food & beverage: $126
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $63 |
| Amgen Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
| PFIZER INC. | 1 | $15 |
Products named: Ozempic, EVENITY, QULIPTA, NURTEC ODT, Wegovy.
